GIP and Insulin resistance: Eriodictyol supplementation in mice fed with a high-fat diet for 16 weeks improved insulin resistance by suppressing hepatic gluconeogenesis, enhancing glucose utilization, and modulating the production and release of gastric inhibitory polypeptide and glucagon-like peptide-1 [95].